Drug Type Fusion protein |
Synonyms DCTY 1109, DCTY1109 |
Target |
Action inhibitors |
Mechanism KRAS inhibitors(GTPase KRas inhibitors) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Intestinal Neoplasms | Preclinical | China | 12 Sep 2023 | |
Pancreatic Cancer | Preclinical | China | 12 Sep 2023 |